Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library AV Room | Available |
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
c.1 BC Cancer Agency ARHCC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library REF | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Library Archives | Available | ||
c.1 BC Cancer Agency VAN Library REF Statistics | Available | ||
c.1 BC Cancer Agency VIC Library REF | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions; Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions; Guidelines on the use of intravenous immune globulin for hematologic conditions; Guidelines…
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
v.1: Investigation and findings; v.2: Looking forward...policy papers; v.3: Appendices
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |